1. Home
  2. CRUS vs GKOS Comparison

CRUS vs GKOS Comparison

Compare CRUS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cirrus Logic Inc.

CRUS

Cirrus Logic Inc.

HOLD

Current Price

$130.49

Market Cap

7.1B

Sector

Technology

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$108.05

Market Cap

6.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRUS
GKOS
Founded
1984
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.9B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
CRUS
GKOS
Price
$130.49
$108.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
14
Target Price
$149.60
$133.07
AVG Volume (30 Days)
588.8K
684.4K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
22.45
N/A
EPS
6.27
N/A
Revenue
$1,896,077,000.00
$507,442,000.00
Revenue This Year
$6.11
$23.39
Revenue Next Year
$1.64
$27.46
P/E Ratio
$21.49
N/A
Revenue Growth
5.99
32.33
52 Week Low
$75.83
$73.16
52 Week High
$146.88
$130.23

Technical Indicators

Market Signals
Indicator
CRUS
GKOS
Relative Strength Index (RSI) 38.80 39.14
Support Level $114.49 $104.72
Resistance Level $135.39 $115.06
Average True Range (ATR) 4.38 4.81
MACD -1.94 -0.91
Stochastic Oscillator 4.75 22.95

Price Performance

Historical Comparison
CRUS
GKOS

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: